• Toggle Accessibility Statement
  • Home
  • Skip to Main Content
  • Sitemap
×
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Code of Conduct
    • Philippine HTA Methods Guide
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Division (HTAD)
    • Road to HTA Institutionalization
    • External Partners
  • Publications
    • Omnibus HTA Tracker
    • Assessments
    • Evidence Briefs
    • Issuances
    • Events and Press Releases
    • Annual Reports
      • 2023 Annual Report
      • 2022 Annual Report
      • 2021 Annual Report
      • 2020 Annual Report
      • 2019 Annual Report
    • FAQs on HTA
  • Get Involved with Us
    • Topic Nomination
    • Call for Proposals
    • Appeals
    • Careers
    • Contact Us
  • AUXILIARY MENU
Menu
GOVPH
  • GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Code of Conduct
    • Philippine HTA Methods Guide
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Division (HTAD)
    • Road to HTA Institutionalization
    • External Partners
  • Publications
    • Omnibus HTA Tracker
    • Assessments
    • Evidence Briefs
    • Issuances
    • Events and Press Releases
    • Annual Reports
      • 2023 Annual Report
      • 2022 Annual Report
      • 2021 Annual Report
      • 2020 Annual Report
      • 2019 Annual Report
    • FAQs on HTA
  • Get Involved with Us
    • Topic Nomination
    • Call for Proposals
    • Appeals
    • Careers
    • Contact Us
    • Accessibility Statement
    • High Contrast
    • Skip to Content
    • Skip to Footer
    • Default Text Size
    • Reduce Text Size - -
    • Enlarge Text Size + +

DOST - Health Technology Assessment Official Logo
Republic of the Philippines
DOST - Health Technology Assessment

Philippine Standard Time:

Evidence brief for 11 September to 17 September 2021

Posted on September 17, 2021

For the period of  11 September to 17 September 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU)     Document Link: 11 September to 17 September 2021

[Department Circular No. 2021- 0400] Inclusion of Tenofovir/Lamivudine/Dolutegravir (TLD) in the Philippine National Formulary (PNF)

Posted on September 10, 2021

Evidence brief for 04 September to 10 September 2021

Posted on September 10, 2021

For the period of  04 September to 10 September 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU)     Document Link: 04 September to 10 September 2021

Evidence brief for 28 August to 03 September 2021

Posted on September 6, 2021

For the period of  28 August to 03 September 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU)     Document Link: 28 August to 03 September 2021

[Department Circular No. 2021- 0376] Interim Requirements for the Health technology Assessment (HTA) of Medical Devices

Posted on September 3, 2021

Post navigation

← Older posts
Newer posts →